Results 31 to 40 of about 2,514 (185)

Innovating Curriculum Systems for Railway Intelligence: Construction and Practice of the AITL Layered Model

Contemporary Education Frontiers
With the rapid advancement of artificial intelligence (AI), traffic engineering is undergoing a critical transformation that requires restructuring both its knowledge framework and talent cultivation model. Traditional railway-related curricula struggle to address highly complex and real-time problems such as transportation organization, train control,
Shengyong Yao, Chen Zhao, Yuhao Dong, Lijuan Liu, Lin Zhou   +4 more
openalex   +2 more sources

Real-world data on clinical outcomes and validation of prognostic models for angioimmunoblastic T-cell lymphoma: a multicentric retrospective study in Southern China. [PDF]

Front Oncol
BackgroundThis study aimed to elucidate the treatment outcomes and prognosis of angioimmunoblastic T-cell lymphoma (AITL) patients in a real-world setting.ObjectivesThe clinical efficacy of new drug applications was evaluated, alongside the predictive ...
Xiang QY, Wu JS, Huang L, Zou ZK, Liu TB, Peng ZG, Lin LE, Wei XL, Zhang HY, Lin Y, Li GW, Jiang YR, Wang H, Shi KQ, Zheng RJ, Han ZJ, Qiu X, Li WY, Zhou JH.   +18 more
europepmc   +2 more sources

LINFOMA DE CÉLULAS T ANGIOIMUNOBLÁSTICO (AITL): UMA VISÃO ONCOGENÉTICA

Hematology, Transfusion and Cell Therapy, 2020
Rayanne Bandeira Carneiro, IC Scharff, W.F. Silva, W.C.A. Junior, IC Scharff, E.V.S. Oliveira, A.E. Gauze, L.L. Hemerly, E.C.O. Coelho, F.J. Junior   +9 more
openalex   +3 more sources

AITL and HES with FIP1L1/PDGFRa fusion gene effectively treated with imatinib [PDF]

Annals of Oncology, 2016
Masayo Yamamoto, Motohiro Shindo, Yasumichi Toki, Mayumi Hatayama, Satoshi Ito, Katsuya Ikuta, Yoshihiro Torimoto   +6 more
openalex   +2 more sources

A case of angioimmunoblastic T-cell lymphoma (AITL)

Skin Cancer, 2010
花輪 書絵, 出口 順啓, 安藤 典子, 原田 和俊, 三森 徹, Tatsuyoshi Kawamura, 柴垣 直孝, 島田 眞路, 小松 則夫   +8 more
openalex   +2 more sources

A Case of Angioimmunoblastic T-cell Lymphoma (AITL)

Journal of UOEH, 2022
A 84-year-old female noticed erythema over her whole body for several months and was referred to our department for evaluation of her skin eruption. A physical examination revealed millet-sized erythematous papules and macules all over her body, a high body temperature, and a decreased level of consciousness. A laboratory examination showed an elevated
Ayaka, Kaneoka, Yoko, Akamatsu, Reiko, Hara, Akiko, Sugiyama, Mihoko, Setoguchi   +4 more
openaire   +3 more sources

KIR3DL2 MUTATION MAY DEFINE A HIGH RATE OF RESPONSE OF AITL TO TIPIFARNIB [PDF]

Hematological Oncology, 2019
Antonio Gualberto, Catherine Scholz, Vishnu S. Mishra, Linda Kessler, Marta Rodríguez, Miguel Á. Piris, Thomas E. Witzig   +6 more
openalex   +2 more sources

Rapid and Durable Complete Remission of Refractory AITL with Azacitidine Treatment in Absence of TET2 Mutation or Concurrent MDS

HemaSphere, 2019
Gareth P. Gregory, Michael Dickinson, Costas K. Yannakou, Jonathan Wong, Piers Blombery, Greg Corboy, Lev M. Kats, Tim Crozier, Beena Kumar, H. Miles Prince, Stephen Opat, Jake Shortt   +11 more
openalex   +5 more sources

Epstein-Barr Virus-Positive Adrenal Diffuse Large B-Cell Lymphoma after Treatment for Angioimmunoblastic T-Cell Lymphoma

European Journal of Case Reports in Internal Medicine, 2021
Angioimmunoblastic T-cell lymphoma (AITL) can be complicated by Epstein-Barr virus (EBV)-positive B-cell lymphoma. B-cell lymphoma may develop simultaneously at the time of AITL diagnosis or after treatment for AITL.
Akiko Hashimoto, Satsuki Asai, Yasuhiro Tanaka, Isaku Shinzato   +3 more
doaj   +1 more source

Autologous stem cell transplantation in major T-cell lymphoma entities: An analysis by the EBMT Lymphoma Working Party. [PDF]

Hemasphere
Abstract Autologous stem cell transplantation (auto‐SCT) is an established treatment for peripheral T‐cell lymphoma (PTCL) to consolidate first remission and for patients with relapsed/refractory (r/r) disease. We aimed to examine the outcomes of patients with PTCL NOS, AITL, and ALK‐negative ALCL undergoing auto‐SCT between 2010 and 2022 and reported ...
Shumilov E, Ngoya M, Berning P, Khvedelidze I, Serroukh Y, Wondergem M, Cwynarski K, Thurner L, Wahlin BE, Zeiser R, Hazenberg C, Nicholson E, Remenyi P, Netelenbos T, Lenhoff S, Tournilhac O, Wilson K, Ho A, Lenz G, Wulf G, Glass B, Dreger P, Sureda A, Damaj G, Bazarbachi A, Schmitz N.   +25 more
europepmc   +2 more sources